250 related articles for article (PubMed ID: 22796798)
1. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?
De Cassan C; Fiorino G; Danese S
Dig Dis; 2012; 30(4):368-75. PubMed ID: 22796798
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: second-generation vs. conventional corticosteroids for induction of remission in ulcerative colitis.
D'Haens G
Aliment Pharmacol Ther; 2016 Nov; 44(10):1018-1029. PubMed ID: 27650488
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic outcomes in a population-based European cohort of 948 ulcerative colitis and Crohn's disease patients by Markov analysis.
Odes S; Vardi H; Friger M; Esser D; Wolters F; Moum B; Waters H; Elkjaer M; Bernklev T; Tsianos E; O'Morain C; Stockbrügger R; Munkholm P; Langholz E
Aliment Pharmacol Ther; 2010 Apr; 31(7):735-44. PubMed ID: 20047578
[TBL] [Abstract][Full Text] [Related]
4. Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis.
Salice M; Rizzello F; Calabrese C; Privitera Hrustemovic H; Gionchetti P
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):607-613. PubMed ID: 31106602
[No Abstract] [Full Text] [Related]
5. Corticosteroid-sparing treatments in patients with Crohn's disease.
Plevy SE
Am J Gastroenterol; 2002 Jul; 97(7):1607-17. PubMed ID: 12135008
[TBL] [Abstract][Full Text] [Related]
6. The role of Budesonide-MMX in active ulcerative colitis.
Gionchetti P; Praticò C; Rizzello F; Calafiore A; Capozzi N; Campieri M; Calabrese C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):215-22. PubMed ID: 24502535
[TBL] [Abstract][Full Text] [Related]
7. Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
Cross RK
Inflamm Bowel Dis; 2017 Oct; 23(10):1689-1701. PubMed ID: 28906290
[TBL] [Abstract][Full Text] [Related]
8. A current overview of corticosteroid use in active ulcerative colitis.
Salice M; Rizzello F; Calabrese C; Calandrini L; Gionchetti P
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):557-561. PubMed ID: 30947569
[TBL] [Abstract][Full Text] [Related]
9. [Local or systemic treatment of inflammatory bowel diseases?].
Schmassmann A; Halter F
Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
[TBL] [Abstract][Full Text] [Related]
10. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
[TBL] [Abstract][Full Text] [Related]
11. Review article: systemic and topical steroids in inflammatory bowel disease.
Schölmerich J
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():66-74. PubMed ID: 15352897
[TBL] [Abstract][Full Text] [Related]
12. [Drug treatment of chronic inflammatory bowel diseases: current status and prospects].
Seibold F; Wagner AC; Göke B
Schweiz Med Wochenschr; 2000 Feb; 130(7):222-32. PubMed ID: 10719713
[TBL] [Abstract][Full Text] [Related]
13. Current status of drug therapy for inflammatory bowel disease.
Peppercorn MA
Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
[TBL] [Abstract][Full Text] [Related]
14. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroids in Crohn's disease.
Yang YX; Lichtenstein GR
Am J Gastroenterol; 2002 Apr; 97(4):803-23. PubMed ID: 12003413
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroids for the management of ulcerative colitis and Crohn's disease.
Jewell DP
Gastroenterol Clin North Am; 1989 Mar; 18(1):21-34. PubMed ID: 2646220
[TBL] [Abstract][Full Text] [Related]
17. Budesonide in the treatment of inflammatory bowel disease.
Silverman J; Otley A
Expert Rev Clin Immunol; 2011 Jul; 7(4):419-28. PubMed ID: 21790284
[TBL] [Abstract][Full Text] [Related]
18. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
Kull E; Beau P
Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
[TBL] [Abstract][Full Text] [Related]
19. Abatacept for Crohn's disease and ulcerative colitis.
Sandborn WJ; Colombel JF; Sands BE; Rutgeerts P; Targan SR; Panaccione R; Bressler B; Geboes K; Schreiber S; Aranda R; Gujrathi S; Luo A; Peng Y; Salter-Cid L; Hanauer SB
Gastroenterology; 2012 Jul; 143(1):62-69.e4. PubMed ID: 22504093
[TBL] [Abstract][Full Text] [Related]
20. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
